Uptake of intermittent preventive treatment for malaria in Nigeria

Abstract

Background: In 2000, the World Health Organization recommended the use of at least 2 doses of intermittent preventive treatment with sulphadoxine-pyrimethamine (IPTp-SP) to reduce the burden of malaria in pregnancy. Aims: This research described the pattern of IPTp-SP uptake among pregnant women. Methods: This study involved re-analyses of the Nigeria Demographic and Health Survey datasets for 2003 and 2008. Frequencies and chi-square (c2) (2x2) tests were used to describe the pattern of IPTp-SP uptake. Findings: The percentage of pregnant women who used any dosage of sulphadoxine-pyrimethamine and at least 2 doses of IPTp-SP increased significantly at P<0.05. There was significant increase whe classified by residence, region, socioeconomic status, education, literacy, partner's education, religion and employment status. Conclusions: Uptake of IPTp-SP is still low and calls for intensified improvement of awareness.

Determinates of Uptake of Intermittent Anti-Malaria Drugs Among Women Attending Ante-Natal Clinic at Chukwuemeka Odumegwu Ojukwu University Teaching Hospital, Awka, Anambra State

“…(2) Subclinical infection due to the presence of parasites in the placenta poses great danger to both the mother and the fetus and can cause miscarriage, stillbirth, preterm birth, low birth weight and congenital malaria. (7) Twenty-five million expectant mothers are as of now at chance of malaria, it accounts for over 10,000 maternal and 200,000 neonatal deaths per year in sub-Saharan Africa. In Nigeria, around 11% of maternal passing was connected to malaria.…”